Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Revenue

    Back to Income Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr

What is the latest Revenue of AUROBINDO PHARMA ?

The latest Revenue ratio of AUROBINDO PHARMA is ₹31,724 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹31,724 Cr
Mar2025₹29,002 Cr
Mar2024₹24,855 Cr
Mar2023₹23,455 Cr
Mar2022₹24,775 Cr

How is Revenue of AUROBINDO PHARMA Trending?

Years Revenue % Change
Mar2026 ₹31,724 Cr
9.39
Mar2025 ₹29,002 Cr
16.68
Mar2024 ₹24,855 Cr
5.97
Mar2023 ₹23,455 Cr
-5.32
Mar2022 ₹24,775 Cr -

Compare Revenue of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹95,130.9 Cr -2.2% 4% 58.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,634.0 Cr -2.9% -2.3% 21.8% Stock Analytics
DIVIS LABORATORIES ₹241,576.0 Cr -1.6% 9.8% 51.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.6% -2.3% 37.5% Stock Analytics
CIPLA ₹111,888.0 Cr -2.2% -6.1% -12.5% Stock Analytics
DR REDDYS LABORATORIES ₹96,322.1 Cr -0.9% -1.8% -9.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.2%

4%

58.6%

SENSEX

-1%

-2.6%

-4.1%


You may also like the below Video Courses